Enregistrement :
6
de
40
(2010-04-30
à
2011-01-14)
Politique ou Programme
Common Drug Review as it relates to reimbursement recommendations decision-making process and framework.
Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
Federal Tobacco Control Strategy as it relates to smoking cessation policy and program initiatives
Science and Technology Strategy, Advantage Canada or any Government policy or program initiatives to support Research and Development in Canada, and advocate for the development of a Biopharma sectoral strategy in support of more research & development in Canada
Politique ou Programme, Règlement
Subsequent Entry Biologics (SEBs): seeking an approval framework supported and protected by Regulations in harmonization with the direction taken by the European Union for instance
Proposition législative, Projet de loi ou résolution
Bill C-6, Canada Consumer Product Safety Act (former Bill C-52) as it relates to creating a new system to regulate consumer products that pose, or might reasonably be expected to pose, a danger to human health and safety.
Proposition législative, Projet de loi ou résolution, Règlement
Food and Drugs Act & Regulations as it relates to Drug Export Restrictions and cross border trade.
The upcoming Food and Drugs Act Modernization legislative proposal (Act and Regulations) as it relates to improving the efficiency of the drug review and approval process.
Règlement
Food and Drugs Act Regulations as it relates to submission & manufacturing approvals of animal health products (Veterinary Drug Directorate).
Patented Medicine Prices Review Board (PMPRB) Regulations as it relates to reporting requirements and pricing guidelines.
Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for therapeutic products.